| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase II Study of the Immunotoxin N901-Blocked Ricin in Small-Cell Lung Cancer
|
Fidias, Panos
|
|
2002
|
3 |
Supplement 1 |
p. 219-222
4 p.
|
artikel
|
| 2 |
Clinical Utility of PET-FDG Imaging in Differentiation of Benign from Malignant Adrenal Masses in Lung Cancer
|
Gupta, Naresh C.
|
|
2001
|
3 |
Supplement 1 |
p. 59-64
6 p.
|
artikel
|
| 3 |
Combined-Modality Therapy for Inoperable non—small-Cell Lung Cancer Using Gemcitabine
|
Curran Jr., Walter John
|
|
2002
|
3 |
Supplement 1 |
p. S17-S21
5 p.
|
artikel
|
| 4 |
Commentary on “Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)”
|
Abratt, Raymond P.
|
|
2002
|
3 |
Supplement 1 |
p. 211-212
2 p.
|
artikel
|
| 5 |
Docetaxel in Second-Line Treatment of non—small-Cell Lung Cancer
|
Fossella, Frank V.
|
|
2002
|
3 |
Supplement 1 |
p. S23-S28
6 p.
|
artikel
|
| 6 |
Docetaxel/Platinum in Advanced non—small-Cell Lung Cancer: Recent Randomized Trials
|
Belani, Chandra P.
|
|
2002
|
3 |
Supplement 1 |
p. S7-S11
5 p.
|
artikel
|
| 7 |
Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) Gene-Transduced Tumor Vaccines(GVAX™) in Non–Small-Cell Lung Cancer
|
Maung, Kavita
|
|
2001
|
3 |
Supplement 1 |
p. 25-26
2 p.
|
artikel
|
| 8 |
Induction and Concurrent Paclitaxel/Carboplatin Every 3 Weeks with Thoracic Radiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: An Interim Report
|
Movsas, Benjamin
|
|
2001
|
3 |
Supplement 1 |
p. 125-132
8 p.
|
artikel
|
| 9 |
Intraluminal Brachytherapy for Malignant Endobronchial Tumors: An Update on Low-Dose Rate Versus High-Dose Rate Radiation Therapy
|
Lo, Theodore C.M.
|
|
2001
|
3 |
Supplement 1 |
p. 65-68
4 p.
|
artikel
|
| 10 |
LY900003 (Affinitac™), an Antisense Inhibitor of Protein Kinase C—α, in Non—Small-Cell Lung Cancer
|
Maung, Kavita
|
|
2002
|
3 |
Supplement 1 |
p. 237-239
3 p.
|
artikel
|
| 11 |
Non–Small-Cell Lung Cancer: Dose Escalation by Target Splitting with Asymmetric Collimation
|
Wurstbauer, Karl
|
|
2001
|
3 |
Supplement 1 |
p. 151-153
3 p.
|
artikel
|
| 12 |
Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)
|
Lyss, Alan P.
|
|
2002
|
3 |
Supplement 1 |
p. 205-210
6 p.
|
artikel
|
| 13 |
Phase II Study of Sequential Treatment of Advanced Non–Small-Cell Lung Cancer: Three Cycles of High-Dose Epirubicin Plus Cisplatin Followed by Weekly Vinorelbine
|
Guaraldi, Monica
|
|
2001
|
3 |
Supplement 1 |
p. 43-46
4 p.
|
artikel
|
| 14 |
Phase I Study of Dose-Dense Alternating Doublets in Advanced Non—Small-Cell Lung Cancer
|
Vokes, Everett E.
|
|
2002
|
3 |
Supplement 1 |
p. 265-270
6 p.
|
artikel
|
| 15 |
Phase I Study of the BLP25 (MUC1 Peptide) Liposomal Vaccine for Active Specific Immunotherapy in Stage IIIB/IV Non–Small-Cell Lung Cancer
|
Palmer, Martin
|
|
2001
|
3 |
Supplement 1 |
p. 49-57
9 p.
|
artikel
|
| 16 |
Photodynamic Therapy for Patients with Advanced Non–Small-Cell Carcinoma of the Lung
|
Jones, Blanding U.
|
|
2001
|
3 |
Supplement 1 |
p. 37-41
5 p.
|
artikel
|
| 17 |
Temozolomide in Non—Small-Cell Lung Cancer: Preliminary Results of a Phase II Trial in Previously Treated Patients
|
Adonizio, Christian S.
|
|
2002
|
3 |
Supplement 1 |
p. 254-258
5 p.
|
artikel
|
| 18 |
The Role of Semaphorins in Lung Cancer
|
Roche, Joélle
|
|
2001
|
3 |
Supplement 1 |
p. 145-150
6 p.
|
artikel
|
| 19 |
The Role of Weekly Docetaxel in the Treatment of Advanced non—small-Cell Lung Cancer
|
Hainsworth, John D.
|
|
2002
|
3 |
Supplement 1 |
p. S17-S22
6 p.
|
artikel
|
| 20 |
Update on Results of Multifield Conformal Radiation Therapy of Non—Small-Cell Lung Cancer Using Multileaf Collimated Beams
|
Bhatnagar, Ajay
|
|
2002
|
3 |
Supplement 1 |
p. 259-264
6 p.
|
artikel
|
Tijdschrift beschrijving